← Browse by Condition
Medical Condition

eczema

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for eczema sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — eczema Clinical Trials

How many clinical trials are currently recruiting for eczema?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for eczema, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for eczema?
eczema research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a eczema clinical trial?
Eligibility criteria for eczema trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Top Sponsors
Universiti Putra Malaysia 1 trial
USMARI Research & Innovation Centre 1 trial
The University of New South Wales 1 trial
Alphyn Biologics 1 trial

Recruiting Clinical Trials

NCT04919265
Recruiting
Mother-Infant Cohort Study in Malaysia and China
Enrollment
200 pts
Location
Malaysia
Sponsor
Universiti Putra Malaysia
View Trial →
NCT07463079
Recruiting
Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema
Enrollment
15 pts
Location
Malaysia
Sponsor
USMARI Research & Innovation C...
View Trial →
NCT06584552 Phase 2
Recruiting
LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema)
Enrollment
100 pts
Location
Australia
Sponsor
The University of New South Wa...
View Trial →
NCT06855745 Phase 2
Recruiting
Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Enrollment
72 pts
Location
Australia
Sponsor
Alphyn Biologics
View Trial →

Related Conditions

atopic dermatitis eczema (2) gut microbiota (1) gastrointestinal symptoms (1) temperament (1) asthma (1) breast milk collection (1) allergy (1) atopic dermatitis (1) atopic dermatitis ad (1) eczema atopic (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology